| Variable | Total Score (N = 58) | |||
| FSFI-19 | QS-F | |||
| ρ | *p-value | ρ | *p-value | |
| Total Score FSFI-19 | - | - | 0.726 | ≤0.05 |
| Total Score QS-F | 0.726 | ≤0.01 | - | - |
| Total Score EORTC QLQ-30 | 0.549 | ≤0.01 | 0.333 | 0.013 |
| Score EORTC—Functional Scale | 0.424 | ≤0.01 | 0.393 | ≤0.01 |
| Score EORTC—Symptom Scale | −0.307 | ≤0.05 | −0.285 | ≤0.05 |
| Score EORTC—Global Health Scale | 0.549 | ≤0.01 | 0.333 | ≤0.05 |
| Depression | −0.322 | ≤0.05 | −0.221 | 0.096 |
| Age at diagnosis | −0.114 | 0.479 | −0.226 | 0.156 |
| Tumor size | −0.047 | 0.731 | −0.101 | 0.461 |
| Lymph node involvement | 0.195 | 0.147 | 0.136 | 0.313 |
| Hormonal receptors | 0.036 | 0.796 | 0.020 | 0.886 |
| HER2 hyperexpressed | 0.344 | 0.092 | 0.423 | ≤0.05 |
| Adjuvant chemotherapy | −0.016 | 0.905 | −0.077 | 0.570 |
| Neoadjuvant chemotherapy | 0.102 | 0.450 | 0.109 | 0.421 |
| General chemotherapy | 0.079 | 0.559 | 0.034 | 0.804 |
| Hormone Therapy | 0.158 | 0.239 | 0.089 | 0.508 |
| Sectorectomy | 0.118 | 0.387 | 0.165 | 0.224 |
| Mastectomy with reconstruction | −0.092 | 0.499 | −0.048 | 0.726 |
| Simple mastectomy | 0.202 | 0.136 | 0.004 | 0.977 |
| Sexual activity last 4 weeks | 0.740 | ≤0.01 | 0.458 | ≤0.01 |